Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood

AAV gene transfer is a promising treatment for many patients with life-threatening genetic diseases. However, host immune response to the vector poses a significant challenge for the durability and safety of AAV-mediated gene therapy. Here, we characterize the innate immune response to AAV in human...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Corinne J., Ross, Nikki, Kamal, Ali, Kim, Kevin Y., Kropf, Elizabeth, Deschatelets, Pascal, Francois, Cedric, Quinn, William J., Singh, Inderpal, Majowicz, Anna, Mingozzi, Federico, Kuranda, Klaudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523746/
https://www.ncbi.nlm.nih.gov/pubmed/36189251
http://dx.doi.org/10.3389/fimmu.2022.999021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523746/
https://www.ncbi.nlm.nih.gov/pubmed/36189251
http://dx.doi.org/10.3389/fimmu.2022.999021

Ejemplares similares